Title : Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.

Pub. Date : 2017 Jan 15

PMID : 27816545






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Abemaciclib (LY2835219) is an orally bioavailable CDK4/6 inhibitor under phase III clinical trials. abemaciclib cyclin dependent kinase 4 Homo sapiens